Ali Tahrioui

Dr. Ali Tahrioui

University of Rouen Normandy
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2019 in npj Biofilms and Microbiomes
Verified
Journal Article
Open access
PDF file
ATAli Tahrioui
Ali Tahrioui
RDRachel Duchesne
Rachel Duchesne
EBEmeline Bouffartigues
Emeline Bouffartigues
SRSophie Rodrigues
Sophie Rodrigues
OMOlivier Maillot
Olivier Maillot
SCSylvie Chevalier
Sylvie Chevalier
Biofilms are structured microbial communities that are the leading cause of numerous chronic infections which are difficult to eradicate. Within the lungs of individuals with cystic fibrosis (CF), Pseudomonas aeruginosa causes persistent biofilm infection that is commonly treated with aminoglycoside antibiotics such as tobramycin. However, sublethal concentrations of this aminoglycoside were previously shown to increase biofilm formation by P. aeruginosa, but the underlying adaptive mechanisms still remain elusive. Herein, we combined confocal laser scanning microscope analyses, proteomics profiling, gene expression assays and phenotypic studies to unravel P. aeruginosa potential adaptive mechanisms in response to tobramycin exposure during biofilm growth. Under this condition, we show that the modified biofilm architecture is related at least in part to increased extracellular DNA (eDNA) release, most likely as a result of biofilm cell death. Furthermore, the activity of quorum sensing (QS) systems was increased, leading to higher production of QS signaling molecules. We also demonstrate upon tobramycin exposure an increase in expression of the PrrF small regulatory RNAs, as well as expression of iron uptake systems. Remarkably, biofilm biovolumes and eDNA relative abundances in pqs and prrF mutant strains decrease in the presence of tobramycin. Overall, our findings offer experimental evidences for a potential adaptive mechanism linking PrrF sRNAs, QS signaling, biofilm cell death, eDNA release, and tobramycin-enhanced biofilm formation in P. aeruginosa. These specific adaptive mechanisms should be considered to improve treatment strategies against P. aeruginosa biofilm establishment in CF patients’ lungs.

1 July 2019 in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Verified
Journal Article
Closed access
SCSylvie Chevalier
Sylvie Chevalier
EBEmeline Bouffartigues
Emeline Bouffartigues
ABAlexis Bazire
Alexis Bazire
ATAli Tahrioui
Ali Tahrioui
RDRachel Duchesne
Rachel Duchesne
PCPierre Cornelis
Pierre Cornelis

1 November 2013 in Microbiological Research
Verified
Journal Article
Closed access
MBMarta Torres Bejar
Marta Torres Bejar
MRManuel Romero
Manuel Romero
SPSusana Prado
Susana Prado
JDJavie Dubert
Javie Dubert
ATAli Tahrioui
Ali Tahrioui
Inmaculada LlamasInmaculada Llamas
Inmaculada Llamas

14 January 2022 in Advanced Science
Verified
Journal Article
Open access
PDF file
MLMélissande Louis
Mélissande Louis
TCThomas Clamens
Thomas Clamens
ATAli Tahrioui
Ali Tahrioui
FDFlorie Desriac
Florie Desriac
SRSophie Rodrigues
Sophie Rodrigues
OLOlivier Lesouhaitier
Olivier Lesouhaitier
Pseudomonas aeruginosa biofilms cause chronic, antibiotic tolerant infections in wounds and lungs. Numerous recent studies demonstrate that bacteria can detect human communication compounds through specific sensor/receptor tools that modulate bacterial physiology. Consequently, interfering with these mechanisms offers an exciting opportunity to directly affect the infection process. It is shown that the human hormone Atrial Natriuretic Peptide (hANP) both prevents the formation of P. aeruginosa biofilms and strongly disperses established P. aeruginosa biofilms. This hANP action is dose‐dependent with a strong effect at low nanomolar concentrations and takes effect in 30–120 min. Furthermore, although hANP has no antimicrobial effect, it acts as an antibiotic adjuvant. hANP enhances the antibiofilm action of antibiotics with diverse modes of action, allowing almost full biofilm eradication. The hANP effect requires the presence of the P. aeruginosa sensor AmiC and the AmiR antiterminator regulator, indicating a specific mode of action. These data establish the activation of the ami pathway as a potential mechanism for P. aeruginosa biofilm dispersion. hANP appears to be devoid of toxicity, does not enhance bacterial pathogenicity, and acts synergistically with antibiotics. These data show that hANP is a promising powerful antibiofilm weapon against established P. aeruginosa biofilms in chronic infections.

24 July 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
ADAudrey David
Audrey David
ATAli Tahrioui
Ali Tahrioui
ATAnne-Sophie Tareau
Anne-Sophie Tareau
AFAdrien Forge
Adrien Forge
MGMathieu Gonzalez
Mathieu Gonzalez
SCSylvie Chevalier
Sylvie Chevalier
Pseudomonas aeruginosa is an opportunistic pathogen causing acute and chronic infections, especially in immunocompromised patients. Its remarkable adaptability and resistance to various antimicrobial treatments make it difficult to eradicate. Its persistence is enabled by its ability to form a biofilm. Biofilm is a community of sessile micro-organisms in a self-produced extracellular matrix, which forms a scaffold facilitating cohesion, cell attachment, and micro- and macro-colony formation. This lifestyle provides protection against environmental stresses, the immune system, and antimicrobial treatments, and confers the capacity for colonization and long-term persistence, often characterizing chronic infections. In this review, we retrace the events of the life cycle of P. aeruginosa biofilm, from surface perception/contact to cell spreading. We focus on the importance of extracellular appendages, mechanical constraints, and the kinetics of matrix component production in each step of the biofilm life cycle.

5 November 2018 in Journal of Innate Immunity
Verified
Journal Article
Open access
PDF file
OLOlivier Lesouhaitier
Olivier Lesouhaitier
TCThomas Clamens
Thomas Clamens
TRThibaut Rosay
Thibaut Rosay
FDFlorie Desriac
Florie Desriac
MLMélissande Louis
Mélissande Louis
MFMarc G.J. Feuilloley
Marc G.J. Feuilloley
Bacterial biofilms constitute a critical problem in hospitals, especially in resuscitation units or for immunocompromised patients, since bacteria embedded in their own matrix are not only protected against antibiotics but also develop resistant variant strains. In the last decade, an original approach to prevent biofilm formation has consisted of studying the antibacterial potential of host communication molecules. Thus, some of these compounds have been identified for their ability to modify the biofilm formation of both Gram-negative and Gram-positive bacteria. In addition to their effect on biofilm production, a detailed study of the mechanism of action of these human hormones on bacterial physiology has allowed the identification of new bacterial pathways involved in biofilm formation. In this review, we focus on the impact of neuropeptidic hormones on bacteria, address some future therapeutic issues, and provide a new view of inter-kingdom communication.